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Abstract
Platyhelminth parasites are a major health problem in
developing countries. In contrast to their mammalian hosts,
platyhelminth thiol-disulfide redox homeostasis relies on
linked thioredoxin-glutathione systems, which are fully
dependent on thioredoxin-glutathione reductase (TGR),
a promising drug target. TGR is a homodimeric enzyme
comprising a glutaredoxin domain and thioredoxin reductase
(TR) domains with a C-terminal redox center containing
selenocysteine (Sec). In this study, we demonstrate the existence
of functional linked thioredoxin-glutathione systems in the
cytosolic and mitochondrial compartments of Echinococcus
granulosus, the platyhelminth responsible for hydatid disease.
The glutathione reductase (GR) activity of TGR exhibited
hysteretic behavior regulated by the [GSSG]/[GSH] ratio.
This behavior was associated with glutathionylation by
GSSG and abolished by deglutathionylation. The Km and kcat
values for mitochondrial and cytosolic thioredoxins (9.5 µM
and 131 s–1, 34 µM and 197 s–1, respectively) were higher than
those reported for mammalian TRs. Analysis of TGR mutants
revealed that the glutaredoxin domain is required for the GR
activity but did not affect the TR activity. In contrast, both
GR and TR activities were dependent on the Sec-containing
redox center. The activity loss caused by the Sec-to-Cys
mutation could be partially compensated by a Cys-to-Sec
mutation of the neighboring residue, indicating that Sec can
support catalysis at this alternative position. Consistent with
the essential role of TGR in redox control, 2.5 µM auranofin,
a known TGR inhibitor, killed larval worms in vitro. These
studies establish the selenium- and glutathione-dependent
regulation of cytosolic and mitochondrial redox homeostasis
through a single TGR enzyme in platyhelminths.
Abbreviations: Sec, selenocysteine; DMEM, Dulbecco’s modified
Eagle’s medium; DTNB, 5,5’-dithiobis(2-dinitrobenzoic acid); DTT,
dithiothreitol; EGFP, enhanced green fluorescent protein; GR,
glutathione reductase; Grx, glutaredoxin; GSSG, glutathione(oxidi
zedform); TGR, thioredoxinglutathione reductase; TR, thioredoxin

reductase; Trx, thioredoxin; SECIS, selenocysteine insertion sequence;
mtTrx, mitochondrial Trx; cTrx, cytosolic Trx.

T

he control of parasitic infections, which are a major cause
of disability, mortality, and economic losses in many
developing countries, remains as one of the most important
challenges for medicine in the 21st century (1). In the case of
the phylum platyhelminthes (flatworms), which include the
causative agents of schistosomiasis (bilharzia) and hydatid
disease, pharmacotherapy with praziquantel has met
great success in the treatment of infection. However, drug
resistance is a serious issue as it has been the case for other
antiparasitic drugs (2). In the case of platyhelminths, this
may have severe consequences, because praziquantel is the
only drug that is readily available for large scale treatment
of these infections (3). Thus, the need for new drugs and/or
vaccines is of great importance. In recent years, evidence has
accrued that the selenocysteine (Sec)2-containing enzyme
thioredoxin glutathione reductase (TGR) is essential for
platyhelminth parasites and has emerged as a rational target
for chemotherapy and/or immunotherapy (4–8). In most
organisms, including the mammalian hosts of platyhelminths,
cellular redox homeostasis, antioxidant defenses, and supply
of reducing equivalents to several targets and essential
enzymes rely on two major pathways: the glutathione (GSH)
and the thioredoxin (Trx) systems, which have overlapping
and differential targets and functions (9, 10). In contrast,
platyhelminth parasites lack conventional thioredoxin
reductase (TR) and glutathione reductase (GR), and hence
conventional Trx and GSH systems (4, 6, 7). Instead, they
rely exclusively on linked thioredoxin-glutathione systems,
with TGR being the key enzyme that provides reducing
equivalents to both pathways. Another feature of the linked
systems in platyhelminths is that cytosolic and mitochondrial
TGR derive from a single gene and have identical sequence,
once the leader peptide of the mitochondrial variant is
removed (5). In the mammalian hosts, different thioredoxin
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reductase isozymes function in the cytosol and the
mitochondria (11, 12), TGR expression is largely restricted
to testis (13), and GR exists as a distinct gene (14). In sum,
the dissimilar arrangements of redox pathways as compared
with their hosts, the lack of back-up systems, and the fact that
parasitic organisms are subjected not only to the endogenous
oxidative stress, but also to the oxidative challenge imposed
by the host’s immune system, provide a strong rationale to
target platyhelminth TGRs. Recent studies support this idea:
inhibition of TGR expression by RNA interference caused
death of the platyhelminth parasite Schistosoma mansoni,
and auranofin, a potent inhibitor of TGR and Sec-containing
TRs (15), caused a partial cure in experimental Schistosoma
infection (8).
TGR possesses a fusion of conventional TR domains with
a glutaredoxin (Grx) domain (13, 16). TGR, like GR and TR,
is a homodimer, with monomers oriented in a head-to-tail
manner. Based on biochemical data, the current model of
the mechanism of reaction for TGR proposes that electrons
flow from NADPH to FAD, to the C156XXXXC redox center
(numeration according to Echinococcus granulosus TGR), to
the C-terminal GC595UG (U is Sec) redox center of the second
subunit, and finally to the C31XXC redox center of the Grx
domain of the first subunit. The fully reduced enzyme can
reduce either oxidized Trx using the C-terminal active site
GCUG, or GSSG through the CXXC redox center of the Grx
domain (13, 17). Recently, a crystallographic structure of an S.
mansoni C-terminally truncated TGR (GCstop) has been solved.
Based on the residual GR activity of the mutant, the authors
proposed an alternative view in which GSSG could be reduced
directly by the CXXXXC redox center of TR domains (18).
In the current study, we have characterized the linked
thioredoxin-glutathione system of the platyhelminth E.
granulosus, the causative agent of hydatid disease. We
demonstrated the occurrence of functional linked systems in
both cytosol and mitochondria. The analysis of activities of
TGR mutants revealed that the Grx domain is required for
the GR activity, but does not affect the TR activity; in contrast,
both Trx- and glutathione-dependent activities require
selenocysteine (Sec) residue. Our results also indicate that
[GSSG]/[GSH] ratio regulates TGR activities and strongly
suggest that glutathionylation/deglutathionylation is involved
in this regulation. In addition, we show that larval worms are
killed by very low concentrations of auranofin, a TGR inhibitor,
and discuss our results in light of the current models that have
been put forward to explain the GR activity of TGR.
Experimental Procedures
Cloning of Mitochondrial Isoforms of Trx and TGR as
N-terminal Fusions to EGFP
To analyze the subcellular localization of the putative
mitochondrial variants of Trx and TGR, constructs were
generated using pEGFP-N2 (Clontech). In the case of Trx, the
sequence was retrieved from Partigen (cluster EGC03292),
and the entire coding region, including the leader peptide,
was cloned as an in-frame fusion to EGFP. In the case
of TGR the N-terminal fragment of mitochondrial TGR,
containing the leader peptide followed by the Grx domain of
TGR, was cloned as an EGFP fusion. In both cases, a Kozak

by

TGR

17899

consensus sequence was included in the forward primer for
initiation of translation at the first AUG codon. For transient
expression, mouse NIH 3T3 cells (ATCC) were cultured in
DMEM supplemented with 10% fetal bovine serum in the
presence of 100 units/ml penicillin and 50 units/ml nystatin.
Transfections were carried out in 35-mm glass bottom culture
dishes using Lipofectamine 2000 (Invitrogen), according to the
manufacturer’s instructions. Transfection mix was prepared
using 3 µg of plasmid DNA (mitochondrial Trx construct,
mitochondrial TGR construct, or pEGFP-N2, used as a control)
and 6 µl of Lipofectamine per dish. Transfections were carried
out in Opti-MEM (Invitrogen) for 8 h. The transfection medium
was replaced with a DMEM culture medium containing
MitoTracker Red CM-H2XRos (Molecular Probes), a marker
of the mitochondrial compartment; cells were incubated for
30 min and then washed twice with DMEM. Transiently
transfected cells were detected by confocal microscopy (BioRad, MRC1024ES laser scanning microscope).
Cloning, Expression, and Purification of Recombinant
TGR and Its Mutants
Different constructs were made for expression of wildtype TGR (TGRGCUG) (where U is Sec, and GCUG is the Cterminal tetrapeptide) and the following mutants: Sec596 to Cys
(TGRGCCG), Sec596 to stop (TGRGC*), Sec596 to Cys, and Cys595
to Sec (TGRGUCG), as well as a mutant lacking the entire Grx
domain of TGR (TRGCUG). In all cases mRNA from trizoled E.
granulosus protoscoleces (larval worms) was used as a template
for reverse transcription and PCR, using ThermoScript reverse
transcriptase (Invitrogen) and Pfu (Fermentas), respectively.
Forward and reverse gene-specific primers were derived
from the previously published TGR sequence (5). In the
case of mutant TGRs, the reverse primers were modified
appropriately. For Sec-encoding constructs (TGRGCUG,
TGRGUCG, and TRGCUG), further engineering of the reverse
primers was needed to specify Sec, because the UGASec codon
requires recoding by an Sec insertion sequence (SECIS) element
present in the selenoprotein mRNAs. Thus, for these constructs,
the reverse gene-specific primer contained, at the 5’-end, the
SECIS element of Escherichia coli formate dehydrogenase H at
a 10-nucleotide distance from the UGASec codon (sequences
of primers for every construct are detailed in supplemental
Table S1). This strategy with a bacterial-type SECIS has been
previously used for C-terminal Sec incorporation in E. coli (19).
The amplified products were first cloned into pGEM-T-easy
(Promega), and the construct sequences were verified prior
to subsequent subcloning into pET28a (Novagen). Constructs
were used to transform E. coli BL21(DE3) cells, or, in the
case of selenoprotein constructs, BL21(DE3) cells previously
transformed with pSUABC, a plasmid that supports high
level expression of genes involved in Sec synthesis and
decoding (selA, selB, and selC) (19). Expression of recombinant
proteins was carried out following the protocol described in a
previous study (20), which has been optimized for expression
of selenoproteins. Essentially, induction of recombinant
proteins was carried out with 100 µM isopropyl 1-thio-β-Dgalactopyranoside at late exponential phase (A600 = 2.4), during
24 h at 24 °C. Recombinant clones were grown in modified LB
media according to a previous study (21), supplemented with
0.1 g/liter cysteine and 0.37 g/liter methionine (22), in the
presence of kanamycin (50 µg/ml), and chloramphenicol (33
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µg/ml); the latter was used only in the case of bacterial cultures
harboring the TGRGCUG, TGRGUCG, and TRGCUG constructs. At
the time of induction the culture was supplemented with 5 µM
sodium selenite, 20 µg/ml riboflavin, 20 µg/ml pyridoxine,
and 20 µg/ml niacin according to a previous study (21). For
recombinant TGRs that did not contain Sec (TGRGCCG and
TGRGC*) the same protocol was followed, except that the
plasmid pSUABC was not used. The bacterial cultures were
centrifuged, and the pellets were resuspended in modified
nickel-nitrilotriacetic acid lysis buffer (300 mM NaCl, 50 mM
sodium phosphate, 20 mM imidazole, pH 7.2) containing 1
mM phenylmethylsulfonyl fluoride and 1 mg/ml lysozyme,
and sonicated (10 pulses of 1 min with 1-min pauses). The
lysates were centrifuged for 1 h at 30,000 x g, and supernatants
were applied to a nickel-nitrilotriacetic acid column (Qiagen),
washed with 300 mM NaCl, 50 mM sodium phosphate, 30 mM
imidazole, pH 7.2, and eluted with 250 mM imidazole. The
protein-containing fractions were applied to PD10 desalting
columns (GE Healthcare) using phosphate-buffered saline, 150
mM potassium chloride, 50 mM sodium phosphate, pH 7.2.
Fractions containing the recombinant proteins were stored at –
70 °C before use. Total protein concentration and FAD content
were determined spectrophotometrically at 280 (ε = 54.24
mM–1 cm–1) and 460 nm (ε = 11.3 mM–1 cm–1), respectively. The
selenium content of selenoproteins was determined by atomic
absorption using a Plasma Emission Spectrometer (JarrellAsh 965 ICP) in Chemical Analysis Laboratory, University of
Georgia. The purity of the recombinant proteins was analyzed
by running 10% SDS-PAGE gels, under reducing conditions,
and by size-exclusion chromatography on a Superose 12
column (GE Healthcare).
Cloning, Expression, and Purification of E. granulosus
Recombinant Mitochondrial and Cytosolic Trx Forms
mRNAs encoding cytosolic and mitochondrial E. granulosus
Trxs were amplified by reverse transcription-PCR from total
larval worm mRNA as described above. Specific forward
and reverse primers for cytosolic and the predicted mature
mitochondrial Trx were derived from previously published
sequences (23) and from Partigene (cluster EGC03292),
respectively. The amplified products were first cloned into
pGEM-T-easy (Promega), sequenced and subsequently
subcloned into pET28a (Novagen) using appropriate
restriction enzymes. Constructs were used to transform E. coli
BL21(DE3) host cells. Expression of recombinant proteins was
carried out following the standard protocol for expression of
recombinant proteins. Essentially, recombinant clones were
grown on LB in the presence of kanamycin, and induction of
recombinant proteins was carried out with 100 µM isopropyl
1-thio-β-D-galactopyranoside at early exponential phase (A600
= 0.5), for 3 h at 37 °C. The bacterial cultures were centrifuged,
and the recombinant proteins were purified and desalted as
described above for TGR, except that all buffers had pH 7.8.
Fractions containing the recombinant proteins were stored
at –70 °C prior to use. Protein concentration was determined
spectrophotometrically at 280 nm (ε = 7.6 and 6.1 mM–1
cm–1 for cytosolic and mitochondrial Trx, respectively). The
purity of the recombinant proteins was analyzed by running
15% SDS-PAGE gels under reducing conditions, and by size
exclusion chromatography on a Superdex 75 column (GE
Healthcare).
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Metabolic Labeling of Selenoproteins
To label cells with 75Se, E. coli cells carrying the different
constructs were grown at 37 °C until A600 reached 0.4, and
the culture was supplemented with ~50 µCi 75Se (as freshly
neutralized sodium selenite, specific activity of 1000 Ci/
mmol, Research Reactor Facility, University of Missouri,
Columbia, MO). After an additional 30 min, isopropyl 1-thioβ-D-galactopyranoside was added to each cell culture at a final
concentration of 100 µM. After 3 h of induction at 37 °C, cells
were collected, washed, and lysed by boiling in SDS-PAGE
sample buffer containing 50 mM 1,4-dithiothreitol (DTT). Cell
lysates were then subjected to SDS-PAGE followed by transfer
of proteins onto a polyvinylidene difluoride membrane. 75Se
signal was visualized with a phosphorimaging device (Fuji).
Enzymatic Assays
Insulin Reduction Assay for Trx Activity—The efficient
reduction of two interchain disulfides of insulin catalyzed
by Trx in the presence of DTT was used as a measure of Trx
activity, according to a previous study (24). The reaction
was followed by the increase in absorbance at 650 nm due to
the precipitation of free insulin B-chain. The 0.8-ml reaction
mixtures contained 0.33 mM DTT, 130 µM insulin, and 2 mM
EDTA in 100 mM potassium phosphate buffer, pH 7.0. Runs
with DTT alone were performed as controls.
DTNB Reduction Assay for TR Activity—The reduction of 5,5’dithiobis (2-dinitrobenzoic acid) (DTNB) with concomitant
NADPH oxidation was determined by the increase in
absorbance at 412 nm due to formation of 5’-thionitrobenzoic
acid at 25 °C (25). The 0.8-ml reaction mixtures contained 0.2
mM NADPH, 5 mM DTNB, and 10 mM EDTA in 100 mM
potassium phosphate buffer, pH 7.0.
Insulin Reduction Assay for TR Activity—The Trx-coupled
assay of TR activity takes advantage of the NADPH-dependent
reduction of Trx by TR, which is followed by the decrease in
absorbance at 340 nm; in this assay, excess of insulin is used
as an electron sink to maintain a constant concentration of
oxidized Trx (25). The 0.8-ml reaction mixtures contained
0.2 mM NADPH, 1 mM EDTA, 0.5 mg/ml insulin, and E.
granulosus cytosolic or mitochondrial Trx (concentrations
ranged from 0 to 80 µM and from 0 to 140µM, respectively),
in 50 mM potassium phosphate buffer, pH 7.0. The kinetic
parameters of TGR with its physiological substrates, cytosolic
and mitochondrial Trx, were determined from MichaelisMenten plots of vo (derived from time-course experiments)
against substrate concentration.
GR Assay—The GR activity was assayed as NADPHdependent reduction of oxidized glutathione (GSSG), which
is followed as the decrease in absorbance at 340 nm (26). The
0.8-ml reaction mixture contained 0.125 mM NADPH, 1 mM
GSSG, 1 mM EDTA in 100 mM potassium phosphate buffer,
pH 7.0.
All enzymatic assays were carried out in a Cary 50 (Varian)
spectrophotometer at 25 °C. Analyses of the kinetic data were
performed using ORIGIN software (OriginLab).
Mass Spectrometry Analysis—Wild-type TGR samples (10
nM concentration) were incubated with GSSG in the presence
or absence of 0.125 mM NADPH at molar ratios under which
hysteresis was or was not observed (1 mM or 30 µM GSSG,
respectively) in 100 mM potassium phosphate buffer, pH 7.0,
containing 1 mM EDTA, and immediately passed through a
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PD10 desalting column (GE Healthcare). Protein-containing
fractions were digested with trypsin and subjected to analysis
by matrix-assisted laser desorption ionization time-of-flight
mass spectrometry (4800 Analyzer, Applied Biosystems). The
mass spectrometry analysis was carried out at the Institut
Pasteur, Montevideo.
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In Vitro Culture of Larval Worms—50,000 protoscoleces,
obtained from asceptical punction of a single hydatid cyst
from bovine lung, were washed several times with phosphatebuffered saline and then incubated at 37 °C, 5% CO2, in
DMEM supplemented with antibiotics and 20 mM HEPES,
pH 7.4. Cultured protoscoleces were treated with 1, 2.5, 5, and
10 µM auranofin or with the vehicle (DMSO), in the presence
or absence of 100 µM hydrogen peroxide. Protoscoleces were
observed under the microscope, and viability was assessed
by exclusion of the vital dye eosin.
Results

Figure 1. Subcellular localization of GFP-fused mitochondrial
TGR and mtTrx. NIH3T3 cells were transiently transfected either
with the non-recombinant pEGFP vector (A) or with the pEGFPderived constructs carrying mitochondrial TGR (B) and mtTrx (C)
N-terminally fused to GFP. Images were obtained at 8 h posttransfection using an I-confocal microscope. A set of three panels
is shown for each construct. Left panels show green fluorescence
corresponding to transiently expressed GFP fusion proteins.
Center panels show the red fluorescence of the mitochondrial dye
(MitoTracker). The right panels show merged images from left and
center panels.

Mitochondrial Localization of Trx and TGR Forms—Sequence
analyses suggested the occurrence of both cytosolic and
mitochondrial forms of TGR and Trx, with TGR forms
generated from a single gene, and two genes for Trx forms.
The results of transient expression in mammalian NIH 3T3
cells of the predicted mitochondrial forms of Trx and TGR
are shown in Figure 1. Both EGFP fusion proteins co-localized
with MitoTracker, indicating that the signal peptides of these
proteins direct the fusions to the mitochondrial compartment.
No obvious staining of the cytosol or other subcellular
compartments was observed. TGR has been previously shown
to be present in the mitochondrial subcellular fraction of a
larval worm aqueous extract (5); however, the mitochondrial
location of Trx was previously limited to in silico predictions
in platyhelminths (7).
TGR Can Provide Electrons to Both Cytosolic and Mitochondrial
Trx Forms—Prior to determining the enzymatic parameters
of TGR with its physiological substrates, the quality of every
recombinant protein was assessed in several ways. First,
the purity of TGR and its mutants, and of cytosolic and
mitochondrial Trx forms, was determined by SDS-PAGE
under reducing conditions (Figure 2A) and by size exclusion
chromatography (data not shown). In the case of selenoproteins,
Sec incorporation was evaluated by metabolic labeling of the
bacterial cultures with 75Se. The results are shown in Figure 2

Figure 2. Analysis of recombinant proteins. A, SDS-PAGE analysis of purified recombinant proteins. After purification on a nickelnitrilotriacetic acid column and desalting, recombinant proteins were run on a 12.5% polyacrylamide gel. 1 µg of each recombinant protein
was loaded on the gel. Lanes 1–5, TGRGCUG, TRGCUG, TGRGUCG, TGRGCCG, TGRGC*, respectively; lane 6, molecular weight markers; lane 7,
mtTrx; and lane 8, cTrx. The positions of molecular weight marker are indicated on the right. B and C. 75Se incorporation into recombinant
TGRs. BL21(DE3) cells expressing TGRGCUG, TGRGUCG, TGRGCCG, and TGRGC* were induced with 100 µM isopropyl 1-thio-β-D-galactopyranoside
for 3 h at 37 °C. 50 µCi of 75Se were added to 10-ml cultures 30 min before induction. Total cell protein samples were resolved by SDSPAGE and transferred onto a polyvinylidene difluoride membrane. B, Coomassie Blue staining of the polyvinylidene difluoride membrane.
C, 75Se detection by phosphorimaging device analysis. Lanes 1–4, 10 µl of total cell protein samples from cells expressing recombinant
TGRGCUG, TGRGUCG, TGRGCCG, and TGRGC*, respectively; lane 5, molecular weight marker. FDH-O, formate dehydrogenase O (110 kDa), the
single selenoprotein expressed by E. coli under aerobic conditions. The bands around 66 kDa are indicated by an asterisk on lanes 1 and 2
on the right panel and correspond to 75Se-labeled Sec-containing recombinant TGRs. Lower molecular mass bands on these lanes probably
correspond to secondary initiation or degradation products of these Sec-containing recombinants. The absence of bands on lanes 3 and 4
indicates no unspecific selenium incorporation was detected. The positions of molecular weight markers are indicated on the right.
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Table 1. Kinetic parameters of wild-type TGR and its
mutants. Apparent kinetic parameters for mtTrx and cTrx
(physiological TGR substrates) were obtained by varying the
mtTrx and cTrx concentrations at a constant and saturating
concentration of NADPH and constant enzyme concentrations.
Apparent kcat values for DTNB were determined from the slope
of the initial velocities (v0) versus enzyme concentration plots
(Figure 4). The enzyme concentrations used for kcat calculations
for selenoproteins (TGRGCUG, TRGCUG, and TGRGUCG) considered the
actual concentrations of active enzymes (i.e. their values were
corrected according to their selenium content).
Parameter

Substrate

Apparent Km
(μm)
Apparent kcat (s–1)
Apparent kcat/Km
(μm–1s–1)

mtTrx
cTrx
mtTrx
cTrx
DTNB
mtTrx
cTrx

TGRGCUG
9.5 ± 0.5
34 ± 2
131 ± 2
197 ± 3
118 ± 3
13.8 ± 0.9
5.8 ± 0.4

TRGCUG

TGRGUCG

TGRGCCG

13.0 ± 0.6

12.0 ± 0.6

14.3 ± 0.6

80 ± 2

6.4 ± 0.2

0.530 ± 0.007

60 ± 3
6.1 ± 0.4

6.0 ± 0.5
0.27 ± 0.03

0.63 ± 0.03
0.037 ± 0.002

Figure 3. Kinetic parameters of TGRGCUG with mtTrx and
cTrx. Apparent Km and kcat of TGRGCUG with mtTrx and cTrx
were obtained using the Trx-coupled assay. The initial reaction
velocities (v0) at different Trx concentrations were measured at
a constant and saturating NADPH concentration (200 µM) and
a constant enzyme concentration (0.5 nM). Plots of v0 versus
substrate concentration for mtTrx and cTrx are shown. The data
were fitted to the Michaelis-Menten equation using Origin 7.5
software. Apparent Km and vmax were obtained from these fittings
and apparent kcat was calculated from apparent vmax. Apparent
Km, kcat, and kcat/Km values are indicated. The enzyme (TGRGCUG)
concentration used for kcat calculation was corrected according to
its selenium content.

(B and C); specific labeling at the expected molecular weight
was observed exclusively in the bacterial lysates expressing
selenoproteins, indicating that full-length selenoproteins were
synthesized. In addition, the selenium content of recombinant
selenoproteins was determined. Sec incorporation was close
to 10% in all recombinant selenoproteins (9.2% for wild-type
TGRGCUG, 7.4% for inverted TGRGUCG, and 8.7% for TRGCUG).
Taken together, all these data indicated that the strategy was
successful to produce full-length TGR in a bacterial host,
although higher percentages of Sec incorporation (up to 50%)
have been previously reported using this methodology for
other selenoproteins (19). Because only a fraction of the TGR
molecules incorporate Sec (due to prevalent termination of
translation at Sec UGA codons), active protein concentrations
of selenoproteins were corrected according to their selenium
content.
The activities of recombinant TGR and Trx were initially
assessed independently of each other, using the DTNB and
insulin reduction assays (see “Experimental Procedures”),
respectively. Both recombinant enzymes displayed activity
in these independent assays (data not shown). Then, using
the insulin coupled assay, the kinetic parameters of TGR with
its physiological substrates, cytosolic and mitochondrial Trx,
were determined from Michaelis-Menten plots of vo against
substrate concentration (Figure 3). Km and kcat values were of
the same order for both Trxs (Figure 3, Table 1). The catalytic
efficiency of TGR was (13.8 ± 0.9) x 106, and (5.8 ± 0.4) x 106
M–1 s–1 for mitochondrial and cytosolic Trx, respectively.
Sec but Not the Grx Domain Is Essential for TR Activity—To
assess the role of the Grx domain and of Sec at the GCUG Cterminal redox center of TGR in the catalysis, we generated a
set of TGR forms: wild-type TGR (TGRGCUG), TRGCUG (without

Figure 4. TR activity of TGR mutants. The TR activities of wildtype and mutant TGRs were compared using the DTNB assay. The
assay was carried out at constant and saturating concentrations of
DTNB and NADPH (5 mM and 200 µM, respectively) and different
concentrations of each enzyme. The plots of initial velocities (v0)
versus enzyme concentration are shown. The selenoenzyme
(TGRGCUG, TRGCUG, and TGRGUCG) concentrations used for kcat
calculations were corrected according to their selenium contents.

the Grx domain), Sec596 to stop mutant (TGRGC*), Sec596 to
Cys mutant (TGRGCCG), and Cys595 to Sec and Sec596 to Cys
double mutant (TGRGUCG). Analysis of TR activity with the
DTNB assay (shown in Figure 4 and summarized in Table
1) revealed that TRGCUG and wild-type TGR have similar
kcat. TGRGC* had negligible activity even at 500 nM enzyme
concentration (data not shown). TGRGCCG had a kcat more than
two orders of magnitude lower than that of wild-type TGR.
The double mutant with Sec and Cys at inverted positions,
TGRGUCG, had a kcat one order of magnitude higher than that
of the Sec596 to Cys mutant. We next evaluated the kinetic
parameters of the mutants with mitochondrial Trx. The results
are summarized in Table 1. The catalytic efficiency (kcat/Km)
of the Sec to Cys mutant was 2.5 orders of magnitude lower
than that of the wild-type TGR, whereas the double mutant
was approximately one order of magnitude higher than the
Cys mutant (Table 1). Both TR assays indicated that, although
the Grx domain did not affect the TR activity, the C-terminal
Sec residue was essential for this activity. Interestingly, a
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Figure 5. Hysteretic behavior
of GR activity of TGR. Full-time
courses obtained using different
assay conditions are shown. In all
cases the reactions were started
by the addition of TGRGCUG at the
indicated final concentrations. A,
effect of enzyme concentration.
Assays were performed at varying
TGRGCUG concentrations and constant
NADPH and GSSG concentrations
(100 µM and 1 mM, respectively). B,
effect of GSSG concentration. GSSG
concentration was varied at constant
NADPH and enzyme concentrations
(100 µM and 10 nM, respectively).
Note that at 31 and 62 µM GSSG
reactions come to their end at
higher A340, i.e. before depleting
NADPH, because GSSG becomes the
limiting reagent. C, effect of GSH
concentration. GSH was included
at various concentrations while
maintaining constant GSSG, NADPH,
and enzyme concentrations (1 mM,
125 µM, and 10 nM, respectively). D,
effect of Trx concentration. cTrx was
added at different concentrations to
reaction mixtures containing 1 mM
GSSG, 125 µM NADPH, and 10 nM
TGRGCUG. The TGRGCUG concentration
considered was corrected according
to its selenium content.

Sec residue at the resolving position of the C-terminal redox
center could partially compensate for the loss of activity due
to Sec to Cys mutation.
GR Activity Exhibits Hysteretic Behavior That Is Dependent
on the Ratio of Oxidized and Reduced Glutathione—A hysteretic
behavior (i.e. the existence of a lag time before catalysis takes
place) of the GR activity of TGR was previously reported for
the TGR of Taenia crassiceps (another platyhelminth parasite)
(6). This behavior has not been reported for E. granulosus, S.
mansoni, or mammalian TGR (5, 13, 27). We observed that E.
granulosus TGR exhibited hysteretic behavior for its GR activity,
which became evident at TGR concentrations below 15 nM
(Figure 5A) or high GSSG concentrations (Figure 5B). Although
the results were analogous to those described for T. crassiceps
TGR, the E. granulosus TGR exhibited less marked hysteresis
(i.e. lower lag times for similar experimental conditions).
Rendón et al. (6) described that preincubation of TGR with GSH
abolishes the hysteretic behavior of the enzyme. We found that
preincubation was not needed to relieve GR hysteresis of E.
granulosus TGR (Figure 5C). Although the lag time correlated
directly with the concentration of GSSG, and inversely with
the concentration of GSH, the maximal slope of the curves did
not significantly change once the enzyme was fully active (see
Figure 5, B and C). We next assayed whether Trx can relieve GR
hysteresis and found that 20 µM Trx, without preincubation,
abolished the hysteretic behavior (Figure 5D).
GR Activity Is Reversibly Regulated by Glutathionylation/
Deglutathionylation—Rendón et al. (6) have postulated that TGR
must possess two GSH-binding sites, one of them regulatory,
with high affinity for reduced GSH. We examined binding of E.
granulosus TGR to a glutathione matrix and found that neither
oxidized nor NADPH-reduced TGR associated with GSH-

agarose. Because the [GSSG]/[GSH] ratio controls the activity
of the enzyme, we reasoned that TGR may be glutathionylated
by GSSG at high concentrations and deglutathionylated by
GSH. Thus, we incubated 10 nM TGR with NADPH and 1
mM GSSG for 1 min (conditions at which the enzyme is still
under hysteresis, see Figure 5B) and for 10 min (the enzyme is
no longer under hysteresis, see Figure 5B). We then subjected
the enzymes to tryptic digest and mass spectrometry analysis.
The results indicated that TGR is glutathionylated at two Cys
residues: Cys88 and Cys354 after 1-min incubation with 1 mM
GSSG and NADPH (supplemental Figure S1). Absence of
NADPH did not prevent glutathionylation. In contrast, after
10-min incubation with 1 mM GSSG and NADPH, TGR was
found to be deglutathionylated (supplemental Figure S1). In
similar experiments, no glutathionylation was found when
10 nM TGR was incubated for 1 min with 30 µM GSSG (a
concentration under which there is no hysteresis, see Figure
5B) with or without NADPH. In all cases, neither the Cys
residues belonging to the Grx active site nor those of the
CXXXXC catalytic redox center of TGR were detected as
glutathionylated peptides; instead, they were detected to be
forming disulfides. Some Cys-containing peptides, including
the Sec-containing peptide could not be detected. Altogether
the results indicated that the enzyme is glutathionylated
at high GSSG concentrations and suggest that it becomes
deglutathionylated once the enzyme is active.
We then tested whether the TR activity was preserved in
TGR at conditions at which the GR activity was under hysteresis.
Because it is not possible to measure the TR activity of TGR in
the presence of GSSG, we incubated 10 nM TGR with 1 mM
GSSG for 1 min (conditions under which there is GR hysteresis
and glutathionylation) and applied the glutathionylated TGR

17904

Bonilla

et al. in

Journal

of

B i o l o g i c a l C h e m i s t r y 283 (2008)

Figure 6. TR activity of TGRGCUG and TRGCUG analyzed at the hysteresis conditions for GR activity. A, the TR activities of untreated
and glutathionylated TGRGCUG were compared using the Trx-coupled assay. B, the GR activities of untreated and glutathionylated TGRGCUG
were compared at 100 µM GSSG. In both A and B the enzyme preparations were assayed at 1 nM TGR concentration and 150 µM NADPH.
It should be noted that, to calculate the volume of enzyme preparation that ought to be used in the assay, glutathionylated TGR was
assumed to be 2-fold diluted following desalting. This approximation could explain the slightly smaller slopes observed for this enzyme
in both assays, as compared with the untreated one. C, the TR activity of TRGCUG was evaluated using the Trx-coupled assay both in the
absence and presence of high concentration (1 mM) GSSG. The enzyme was assayed at 1 nM final concentration and 150 µM NADPH. The
selenoenzyme (TGRGCUG and TRGCUG) concentrations considered were corrected according to their selenium contents.

Figure 7. GR activity of TGR mutants. Time courses obtained for the GR activity of wild-type TGR and its mutants are shown. In all
cases the reaction was started by the addition of the enzymes at the indicated final concentrations. A, comparison of the GR activity
of TGRGCUG, TGRGCCG, TGRGC*, and TRGCUG at 31 µM GSSG and 125 µM NADPH. B, the GR activity of TGRGUCG at different enzyme
concentrations was evaluated at 31 µM GSSG and 125 µM NADPH. C, the effect of GSH addition on the hysteretic behavior of TGRGUCG
was studied by including GSH at 1 mM in a reaction mixture containing 1 mM GSSG, 125 µM NADPH, and 25 nM TGRGUCG. The enzyme
concentrations for selenoproteins (TGRGCUG, TRGCUG, and TGRGUCG) were corrected according to their selenium contents.

to a PD10 desalting column to remove GSSG. We measured
the TR activity of this treated TGR by both the insulin-coupled
(Figure 6A) and DTNB assays (data not shown) finding no
hysteretic behavior. In contrast, the GR activity of the treated
TGR was under hysteresis at low GSSG concentrations
(condition under which there is no hysteresis if the enzyme
was not pretreated) (Figure 6B). In addition, we examined
whether Grx domain contributed to glutathionylation. For
this purpose, we evaluated glutathionylation and TR activity
of TRGCUG at high [GSSG]. We found that the TR activity was
unaffected at high [GSSG] using the Trx-coupled assay (Figure
6C); however, the peptide containing Cys354 was not detected
in TRGCUG (either native or glutathionylated).
Both the Grx Domain and the Sec Residue Are Essential for GR
Activity—We further investigated whether the GR activity
was affected by the Grx domain and the Sec residue at the Cterminal redox center. TRGCUG, TGRGCCG, and TGRGC* did not
display significant activity at the standard conditions of the
assay (i.e. 1 mM GSSG), even at high concentrations of enzymes
(200 nM). Because the phenomenon of hysteresis observed
for the GR activity is dependent not only on the enzyme
concentration, but also on GSSG and GSH concentrations,

we evaluated the activity of these mutants at high enzyme
concentrations (200 nM) and different concentrations of
GSSG and in the presence of GSH. None of these enzymes
exhibited significant activity at low GSSG concentrations (30
µM) (Figure 7A), and addition of 1 mM GSH did not affect
the enzymatic activity (data not shown). Altogether, these
results indicated that the C-terminal and Grx redox centers
are essential for GR activity. Interestingly, and similar to what
was observed for the TR activity, the double mutant TGRGUCG
exhibited significant GR activity (Figure 7B). We then studied
the effect of GSH addition on the GR activity of the double
mutant. At high concentration of GSSG (1 mM), the addition
of 1 mM GSH abolished hysteresis (Figure 7C). Finally, we
examined whether a combination of functional TR domains
(TRGCUG) with functional Grx domain (TGRGC*) displays GR
activity. No activity was observed at high concentrations of
both proteins, indicating that electron transfer between these
two proteins is not efficient. This also rules out the possibility
that the ~10-fold Grx excess with respect to functional TR
domains present in TGRGCUG and TGRGUCG (due to the
prevalent truncated forms present in these preparations) can
affect the GR activity of these selenoproteins.
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Figure 8. Auranofin effect on
E.
granulosus
larval
worms.
Protoscoleces were incubated in vitro
at 37 °C, 5% CO2 in DMEM with 10
µM auranofin, a TGR inhibitor, or its
vehicle (DMSO) as a control. A, control
protoscoleces after 30 h of culture.
B, treated protoscoleces after 12 h
of culture (all protoscoleces were
dead, note the disorganization of the
parenchyma and the loss of the hooks
or the entire crown of hooks). C, treated
protoscoleces after 30 h of culture. The
scale bar on C corresponds to 100 µm.

Figure 9. Hysteretic behavior and glutathionylation of TGR.
At high GSSG concentrations, the GR activity of TGR exhibited
hysteretic behavior (filled squares); TGR was found to be
glutathionylated under hysteresis and deglutathionylated once
hysteresis was abolished. At low GSSG concentrations, the GR
activity did not exhibit hysteretic behavior (open squares), and
the enzyme was not glutathionylated. The figure also shows that
hysteretic behavior is favored by high [GSSG]/[GSH] ratios or low
enzyme concentrations and is relieved at low [GSSG]/[GSH] ratios
or high enzyme concentrations.

Auranofin, a TGR Inhibitor, Kills Larval Worms at Low
Concentrations—Because glutathione
and
thioredoxin
activities depend on TGR in both compartments, mitochondria
and cytosol, we evaluated, in animal culture, the effects of
auranofin on protoscoleces (larval worms). All protoscoleces
were dead 12 h after addition of 10 µM auranofin. The
disruption of protoscoleces tegument integrity was the first
microscopic sign of the drug effect; latter changes included
disorganization of the protoscolex parenchyma (Figure 8).
At 5 µM auranofin, 20% of protoscoleces were dead at 12
h, and 100% at 30 h. At 2.5 µM auranofin, all protoscoleces
were dead after 48 h, whereas at 1 µM auranofin, 90% of
protoscoleces survived, but development toward cyst was
severely compromised. We then evaluated the effect of
auranofin on protoscoleces subjected to oxidative stress (100
µM hydrogen peroxide). A lower percentage of protoscoleces,
only 60%, survived at 1 µM auranofin.
Discussion
Previous studies have shown that TGR is an essential
enzyme in platyhelminth parasites and an attractive target
for drug and/or vaccine development (8). In this study,
we provide further evidence that validates TGR as a key

platyhelminth molecule to target. We have previously shown
that cytosolic and mitochondrial variants of TGR from E.
granulosus derive from a single gene and have the same amino
acid sequence, once the leader peptide of the mitochondrial
isoform is removed. We now show, by transient expression
in eukaryotic cells that the mitochondrial variant of TGR and
a putative mitochondrial Trx from E. granulosus localize to
the mitochondrial compartment when assessed by confocal
microscopy. No experimental evidence for mitochondrial colocalization of platyhelminth TGR and Trx had been previously
reported. We thus also proved that TGR provides electrons to
E. granulosus cytosolic and mitochondrial Trxs as well as to
GSSG, indicating the existence of TGR-dependent functional
thiol systems in cytosol and mitochondria. Furthermore,
TGR functions equally well with both Trx isozymes, with a
catalytic efficiency of 107 M–1 s–1, similar to the values reported
for other TGRs and TRs. The Km and kcat values for Trxs are
higher than those reported for mammalian TRs (~3 µM and
40 to 60 s–1, respectively) (15, 28, 29). However, Km values
of the TGRs of the phylogenetically closest organisms to E.
granulosus (T. crassiceps and S. mansoni) are also higher than
those for mammalian TRs. The reported kcat values for these
TGRs are lower than the reported herein for E. granulosus
TGR, but it should be noted that no corrections by protein
selenium content have been done in those cases (6, 8).
During characterization of the GR activity of E. granulosus
TGR we observed that at low concentrations the enzyme
exhibited hysteretic behavior. Furthermore, we showed that
the [GSSG]/[GSH] ratio controlled the activity of the enzyme:
the lag time correlated directly with GSSG concentration
and inversely with GSH concentration. Hysteretic behavior
has been associated with changes in conformation and/
or oligomerization in response to substrates, products, or
modifiers (30). We did not detect changes in the oligomerization
state of TGR upon incubation of the enzyme with high GSSG
concentrations by size exclusion chromatography (data not
shown). Our results strongly indicated that the observed
hysteretic phenomenon correlated to the glutathionylation
state of TGR as summarized in Figure 9. Further evidence that
the hysteretic behavior of TGR was due to glutathionylation
derived from the fact that, once GSSG was removed using
a desalting column, the glutathionylated enzyme was
hysteretic even at low GSSG concentrations. Of the two Cys
residues found to be glutathionylated, Cys88 is present in
vertebrate TGRs and in Grx, whereas Cys354 is present only
in E. granulosus TGR (supplemental Figure S2). Interestingly,
Cys88 is close to the mobile linker of Grx-TR domains (100–
105), and Cys354 is located close to a solvent accessible mobile
loop (359–363) (18). Glutaredoxins have been shown to
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catalyze deglutathionylation of target proteins (31–33). Thus,
an additional issue relates to whether deglutathionylation is
autocatalyzed by TGR. We observed deglutathionylation of
TGR by GSH in the absence of NADPH (data not shown).
This suggests that deglutathionylation under these conditions
can occur, but catalysis by the Grx domain cannot be ruled
out. Because TGR catalyzes numerous thiol-(selenol)-based
reactions, and at the same time its activity is controlled
by the [GSSG]/[GSH] ratio, it constitutes an interesting
model to study enzymatic regulation by glutathionylation/
deglutathionylation, as well as substrate inhibition and
product activation phenomena.
The fact that hysteresis is found at high GSSG concentrations
raises the question of whether this phenomenon takes place in
vivo. It should be noted that parasites are under oxidative stress
mainly due to the host’s immune response. This generates
not only GSSG, but also thiyl radicals, sulfenic acids, and Snitrosylated glutathione and protein intermediates, which
have been proposed as glutathione donors and acceptors for
protein-SSG formation, respectively (34). Glutathionylation of
proteins has been proposed to regulate diverse intracellular
signaling pathways, particularly in mammalian cells under
oxidative stress (9, 31, 34) and to provide a protective
mechanism for the damaging effects of oxidative agents
(34, 35). Our results indicated that TGR activity is preserved
for reduction of Trx during oxidative stress; under these
conditions TGR would be inactivated for the GR function,
whereas the TR function would remain unaffected.
To gain further insights into the catalytic mechanism of
TR and GR activities of TGR, we generated a set of constructs
designed to study the roles of its C-terminal redox center
and the N-terminal Grx domain. Consistent with the results
obtained for mammalian TGR (17), we found that the Sec
residue of TGR is essential for both activities. The Sec to
stop mutant (a truncated mutant at the penultimate amino
acid) has negligible GR and TR activities. Furthermore, a
Sec to Cys mutation also results in a remarkable loss of TR
activity and almost complete loss of GR activity. These results
indicated that in E. granulosus the overall redox homeostasis is
controlled by TGR and is dependent on selenium. A striking
observation was that the additional mutation at the C-terminal
redox center (TGRGUCG) partially compensated for the loss of
activity caused by the single Sec to Cys mutation (TGRGCCG).
This recovery of activity was observed with all substrates
studied: DTNB, thioredoxin, and GSSG. Selenoprotein redox
active sites are characterized by the presence of Sec at the
nucleophilic (attacking) position, and a Cys residue is usually
observed at the resolving position of the catalytic mechanism
(17, 36–38). The higher nucleophilicity and low pKa of the
selenol group of Sec (39) are thought to confer Sec a catalytic
advantage over Cys at the attacking position. In addition,
recent evidence supports the model that Sec is the leaving
group during reduction of the C terminus during the catalytic
cycle (38). No natural selenoprotein with Sec at the resolving
position has been described (40), and it is assumed that Sec
would not confer a significant advantage to the catalytic
efficiency when present at this position. Furthermore, a
semisynthetic mammalian TR with an inverted C-terminal
active site resulted in 100-fold decrease in catalytic activity
(comparable to the Sec to Cys mutant) (38). Our results
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suggest that Sec not only provides a catalytic advantage over
Cys at the nucleophilic position, but a Cys to Sec mutation
at the resolving position can also enhance enzymatic activity
compared with the corresponding Cys form. The fact that
Sec is superior to Cys at the resolving position of the redox
active center may also apply to other selenoproteins and the
corresponding thiol oxidoreductases. It would be interesting
to explore this possibility in the context of engineering Cyscontaining enzymes for enhanced catalysis.
Regarding the role of the Grx domain in TGR functions,
the comparison of wild-type TGR and TR revealed that the
Grx domain does not positively or negatively affect the TR
activity of the enzyme, indicating that the Grx domain neither
assists nor hinders the TR activity of TGR. In contrast, the TR
module of TGR has no GR activity, and thus both the Grx and
TR domains are needed for this activity.
Our data clearly indicate that efficient GSSG reduction
requires both the C-terminal Sec-containing redox center and
the N-terminal Grx domain, in agreement with the model
originally proposed for mammalian TGR (13), and later
supported by characterization of the enzyme (17). This model
put forward that electrons can flow from the C-terminal
GCUG redox center directly to Trx, or to the N-terminal
CXXC redox center of the Grx domain and finally to GSSG.
This implies that a conformational switch must exist to allow
either Trx or the “in built” Grx domain to receive electrons
from the C-terminal redox center. An alternative electron
pathway for GSSG reduction has recently been suggested
based on the crystallographic structure of a C-terminally
truncated S. mansoni TGR. To account for the residual GR
activity of the truncated enzyme, the authors proposed that
GSSG could be reduced directly by the CXXXXC redox center
of TR domains (18). The fact, that auranofin, an inhibitor of
Sec-containing TRs and TGRs, inhibits not only TR but also
GR activities of S. mansoni TGR, suggests that the proposed
alternative electron pathway is marginal and is unlikely to be
physiologically relevant (8, 27).
Finally, we performed in vitro studies on E. granulosus larval
worms to evaluate the effects of auranofin. Concentrations
as low as 2.5 µM of auranofin kill all larval worms within
48 h, and lower concentrations severely hampered in vitro
development of larval worms toward cyst. The effect of the
drug on larval worms challenged with hydrogen peroxide
was even more marked. Low concentrations of auranofin
have also been reported to rapidly kill juvenile and adult S.
mansoni in culture. Mammalian cells, however, are able to
survive higher concentrations of auranofin (8).
Data available indicate that in platyhelminth parasites the
biochemical scenario of thiol-disulfide redox homeostasis
differs greatly from that of their mammalian hosts. In
platyhelminths, the overall redox homeostasis is controlled
by TGR and is dependent on selenium. The substitution of
conventional Trx and GSH systems by linked systems makes
TGR (the molecular link for Trx and glutathione-dependent
functions) a target molecule for drug or vaccine development.
In this study, we demonstrated the existence of functional
linked systems in both mitochondria and the cytosol that
depends on a single TGR. Thus, targeting this enzyme can
be safely expected to compromise the overall cellular redox
homeostasis in these organisms.
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Supplemental Figures 1 & 2 and Supplemental Table 1 follow.

Bonilla et al. Supplemental Fig. 1.
Mass spec of tryptic digest of TGR incubated with GSSG under different
conditions and applied to a PD10 column to remove GSSG.
Sample 1: 10 nM TGR, 1 mM GSSG, 1 minute incubation with NADPH (enzyme
under hysteresis)
Peptide: C354LEEYDPESGK (m/z without modification = 1269.52; m/z glutathionylated =1574.5251)
A. Native peptide range
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Peptide: GEFIGGC88DDVMAIDDDTIVK (m/z = 2112.93; m/z glutathionylated =2417.93)
A. Native peptide range
2126.20
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B. Glutathionylated peptide range
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Sample 2: 10 nM TGR, 1 mM GSSG, 10 minutes incubation with NADPH
(hysteresis relieved)
Peptide: C354LEEYDPESGK (m/z without modification = 1269.52; m/z glutathionylated =1574.5251)
A. Native peptide range
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4700 Reflector Spec #1 MC=>BC=>NF0.7=>MC[BP = 1269.5, 841]
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B. Glutathionylated peptide range
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Peptide: GEFIGGC88DDVMAIDDDTIVK (m/z = 2112.93; m/z glutathionylated =2417.93)
A. Native peptide range

2112.98
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B. Glutathionylated peptide range
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Sample 3: 10 nM TGR, 0.03 mM GSSG, 1 minute incubation without NADPH
(conditions of no hysteresis)
Peptide: C354LEEYDPESGK (m/z without modification = 1269.52; m/z glutathionylated =1574.5251)
A. Native peptide range
1269.5004
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Peptide: GEFIGGC88DDVMAIDDDTIVK (m/z = 2112.93; m/z glutathionylated =2417.93)
A. Native peptide range
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B. Glutathionylated peptide range
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Sample 4: 10 nM TGR, 0.03 mM GSSG, 1 minute incubation with NADPH
(conditions of no hysteresis)
C354LEEYDPESGK (m/z without modification = 1269.52; m/z glutathionylated =1574.5251)
A. Native peptide range
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B. Glutathionylated peptide range
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Peptide: GEFIGGC88DDVMAIDDDTIVK (m/z = 2112.93; m/z glutathionylated =2417.93)
A. Native peptide range
4700 Reflector Spec #1 MC=>BC=>NF0.7=>MC[BP = 1269.5, 1852]
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B. Glutathionylated peptide range
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Bonilla et al. Supplemental Figure 2
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------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------GVRVASEGSVRRPSGPVPAPQPPAFRFVSRPGRARSESETLERSPPQSPGPGKAGDAPNR
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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----------------------MAPI---GGSAEQVEKLRNKINNAAVLVFAKSFCPYCK 35
----------------------MAPI-----PDDTSSWVKKTINSSAVLLFSKSRCPYCR 33
---MFWFRSFCMIGGFCSNSFNMPP------IDGTSQWLQRTIESAAVIVFSKTTCPFCK 51
----------------------MPP------ADGTSQWLRKTVDSAAVILFSKTTCPYCK 32
----------------------MPPIENDAGREQIRSKIKELIDSSAVVVFSKSFCPFCV 38
----------------------MPPT----GRDLLQARVKELIDSNRVMVFSKSFCPYCD 34
RSGHVRGARVLSPPGRRARLSSPGPSRSSEAREELRRHLVGLIERSRVVIFSKSYCPHST 120
--------------------------------------------------------------------------------------------MAQEFVNCKIQPGKVVVFIKPTCPYCR 27
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KVMERFNNLKIPFGYLDLDLKKNG---SDYQKMLQEITGRTTVPQVFFRGEFIGGCDDVM 92
AVKQIFNDDKVNHAVIELDKRPDG---AKIQQVLSQISGISTVPQVFVRGEFVGDSSTIS 90
KLKDVLAEAKIKHATIELDQLSNG---SVIQKALSNFSKIETVPQMFVRGKFIGDSKAVL 108
KVKDVLAEAKIKHATIELDQLSNG---SAIQKCLASFSKIETVPQMFVRGKFIGDSQTVL 89
KVKDLFKELNVKCNTIELDLMEDG---TNYQDLLHEMTGQKTVPNVFINKKHIGGCDNTM 95
RVKDLFSSLGAEYHSLELDECDDG---SDIQEALQELTGQKTVPNVFVNKTHVGGCDKTL 91
RVKELFSSLGVECNVLELDQVDDG---ARVQEVLSEITNQKTVPNIFVNKVHVGGCDQTF 177
-----------------------------------------------------------RAQEILSQLPIKQGLLEFVDITATNHTNEIQDYLQQLTGARTVPRVFIGKDCIGGCSDLV 87
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AID-DD-TIVKKANEM--KYDYDMVIIGGGSGGLALAKESAKSGAKVALLDFVVPTPMGT
KLKKED-KLTEVIKKN--TYDYDLVVIGGGSGGLAASKEAARFGAKTAVFDFVVPTPQDT
NYHNNN-QLQAIVNEN--KYDYDLIIIGGGSGGLAAGKEAAKYGAKTAVLDYVEPTPMGT
KYYSND-ELAGIVNES--KYDYDLIVIGGGSGGLAAGKEAAKYGAKTAVLDYVEPTPIGT
KAHKDG-VLQKLLGEGSEVYDYDLIVIGGGSGGLACSKEAATLGKKVMVLDYVVPTPQGT
QAHKDG-SLAKLLDDNSVTYDYDLIVIGGGSGGLACSKEAASFGKKVMVLDFVVPTPQGT
QAYQSG-LLQKLLQED-LAYDYDLIIIGGGSGGLSCAKEAAILGKKVMVLDFVVPSPQGT
---------MNGPEDLPKSYDYDLIIIGGGSGGLAAAKEAAQYGKKVMVLDFVTPTPLGT
SLQQSGELLTRLKQIGALQ-----------------------------------------
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TWGLGGTCVNVGCIPKKLMHQAALLNHYMEDAKSFGWDVDKG--PHDWVKMVEGIQDHIH
TRGLGGTCVNVGCIPKKLMHQAALLREGMPDSVHFGWKWDPEKIEHDWAQIVENIGNHIH
TWGLGGTCVNVGCIPKKLMHQAGLLSHSLEDAQHFGWSLDKSKISHDWSTMVEGVQSHIG
TWGLGGTCVNVGCIPKKLMHQAGLLSHALEDAEHFGWSLDRSKISHNWSTMVEGVQSHIG
AWGLGGTCVNVGCIPKKLMHQTALLGTAMEDARKFGWEFAEQ-VTHNWETMKTAVNNYIG
SWGLGGTCVNVGCIPKKLMHQAAILGQSLKDSRKFGWEYEEQ-VKHNWETMREAIQNYIG
SWGLGGTCVNVGCIPKKLMHQAALLGQALCDSRKFGWEYNQQ-VRHNWETMTKAIQNHIS
RWGLGGTCVNVGCIPKKLMHQAALLGQALQDSRNYGWKVEET-VKHDWDRMIEAVQNHIG
------------------------------------------------------------
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ALNFGYRSSMMNANVKYLNALGEIVDPHTIKTTNKQGIVKNITTNTIIVATGERPRYPPI
SLNWGYRTQLRSINVEYVNAFAEVVDPHTIKYTKKNKETGTVTAKVIILATGERPRYPGI
SLNWGYKVSLRDNAVTYLNARGMLLNPHEVQITEKNKKVSTITGNKIILATGERPKYPEI
SLNWGYKVALRDNQVTYLNAKGRLISPHEVQITDKNQKVSTITGNKIILATGERPKYPEI
SLNWGYRVSLRDKNVNYVNAYAEFVEPHKIKATNKRGKETFYTAAQFVLATGERPRYLGI
SLNWGYRVALRDKQVRYENAYGEFVESHKIKATNKKGKESFFTAEKFVVATGERPRYLNI
SLNWGYRLSLREKAVAYVNSYGEFVEHHKIKATNKKGQETYYTAAQFVIATGERPRYLGI
SLNWGYRVALREKKVVYENAYGQFIGPHRIKATNNKGKEKIYSAERFLIATGERPRYLGI
------------------------------------------------------------
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PGAKEYGITSDDLFTLDHNPGKTLCVGASYVSLECAGFLSSIGCDVTVMVRSIFLRGFDQ
PGDKEYAITSDDLFWLPYPPGKTLVVGASYVALECAGFLTRFGFDTTVMVRSIFLRGFDQ
PGAIEYGITSDDLFSLPYFPGKTLVVGASYVALECAGFLASLGGDVTVMVRSILLRGFDQ
PGAVEYGITSDDLFSLPYFPGKTLVIGASYVALECAGFLASLGGDVTVMVRSILLRGFDQ
PGDKEFCITSDDLFSLPYCPGKTLVVGASYVALECGGFLAGLGLDVTIMVRSILLRGFDQ
PGDKEYCITSDDLFSLPYCPGKTLVVGASYVALECAGFLAGIGLDATVMVRSIFLRGFDQ
QGDKEYCITSDDLFSLPYCPGKTLVVGASYVALECAGFLAGFGLDVTVMVRSILLRGFDQ
PGDKEYCISSDDLFSLPYCPGKTLVVGASYVALECAGFLAGIGLDVTVMVRSILLRGFDQ
------------------------------------------------------------
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QMAGLISDYIAKYGVKFVRPCVPTSVRCLEEYDPESGKLAIYEVEGKHEDG-TPFKDT
QMADMIGEYMKEHGTKFVRSCVPTAIEEIEARDKENQKPGLYRVKGKYENG-EEFVGE
QMAEKVGDYMENHGVKFAKLCVPDEITQLKPVDTENNKPGLLLVKGHYTDG-KKFEEE
QMAEKVGDYMENHGVKFAKLCVPDEIKQLKVVDTENNKPGLLLVKGHYTDG-KKFEEE
DMADRAGEYMETHGVKFLRKFVPTKIEQLEA-----GTPGRIKVTAKSTESEEFFEGE
EMANRAGAYMETHGVKFIKQFVPIKVELLEE-----GTPGRIKVTAKSTQGDQIIEDE
EMAEKVGSYMEQHGVKFLRKFIPVMVQQLEK-----GSPGKLKVLAKSTEGTETIEGV
DMANKIGEHMEEHGIKFIRQFVPIKVEQIEA-----GTPGRLRVVAQSTNSEEIIEGE
----------------------------------------------------------
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FNTVLFAVGRDPCTTNIGLQNVDVKT--TNGRVVVDDEERTNVPNIYAIGDVSNAGYQLT
FNTIVMAIGRDPTWDRKAMESVGLKLD-KAKRVICADNEQSSVDSIYAIGDIVSGKPQLT
FETVIFAVGREPQLSKLNCEAVGVKLD-KNGRVVCSDDEQTTVSNIYAIGDINAGKPQLT
FETVIFAVGREPQLSKVLCETVGVKLD-KNGRVVCTDDEQTTVSNVYAIGDINAGKPQLT
YNTVLIAVGRDACTGKIGLDKAGVKINEKNGKVPVNDEEQTNVPHIYAIGDILEGKWELT
YNTVLIAVGRDACTRNIGLEKIGVKINERNGKIPVSDEEQTSVPHVYAIGDILDGKLELT
YNTVLLAIGRDSCTRKIGLEKIGVKINEKSGKIPVNDVEQTNVPYVYAVGDILEDKPELT
YNTVMLAIGRDACTRKIGLETVGVKINEKTGKIPVTDEEQTNVPYIYAIGDILEDKVELT
------------------------------------------------------------
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PLAIQAGKNLARRLYTADDCRTDYTNVPTTVFTPLEYGCIGLSEENAISKFGEDNIEVF
PVAIHAGRYLARRLYAGDIELTDYVNVPTTIFTPIEYGACGLSEEDAITKYGKENIEVY
PVAIHAGRYLARRLFAGATELTDYSNVATTVFTPLEYGACGLSEEDAIEKYGDNDIEVY
PVAIQAGRYLARRLFAGATELTDYSNVATTVFTPLEYGACGLSEEDAIEKYGDKDIEVY
PVAIQAGKLLARRLYAGATMKCDYVNVPTTVFTPMEYGSCGHPEEKAIQMYGQENLEVY
PVAIQAGRLLARRLYRGSKVKCDYINVPTTVFTPLEYGCCGYAEEKAIEIYGEENLEVY
PVAIQSGKLLAQRLFGASLEKCDYINVPTTVFTPLEYGCCGLSEEKAIEVYKKENLEIY
PVAIQAGRLLAQRLYAGSTVKCDYENVPTTVFTPLEYGACGLSEEKAVEKFGEENIEVY
-----------------------------------------------------------
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HSYFQPLEWTVPHRPDNTCYAKLIINKQDDNRVVGFHVFGPNAGEVTQGYAVAMHLGAR
HSHFIPLEWTVPHRPED-GYAKIICLKSDSERVIGLHVLGPNAGEMTQGFSVAMKAGAT
HSHFKPLEWTVAHREDNVCYMKLVCRISDNMRVLGLHVLGPNAGEITQGYAVAIKMGAT
HSNFKPLEWTVAHREDNVCYMKLVCRKSDNMRVLGLHVLGPNAGEITQGYAVAIKMGAT
HSLFWPLEFTVPGRDNNKCYAKIICNKLDNLRVIGFHYLGPNAGEVTQGFGAAMKCGIT
HTLFWPLEWTVPSRDNNTCFAKIICNKQDNDRVIGFHVLGPNAGEITQGFGAAMKCGLT
HTLFWPLEWTVAGRENNTCYAKIICNKFDHDRVIGFHILGPNAGEVTQGFAAAMKCGLT
HSYFWPLEWTIPSRDNNKCYAKIICNTKDNERVVGFHVLGPNAGEVTQGFAAALKCGLT
----------------------------------------------------------KEDFDRTIGIHPTCSETFTTLRVTKSSGASATVTGCUG
KADFDRTIGIHPTCFEGFTTMHVTKDSGASAKVTACUG
KEDFDRTIGIHPTCSETFTTLHVTKRSGGSAAVTGCUG
KADFDRTIGIHPTCSETFTTLHVTKKSGVSPIVSGCUG
KDQLDNTIGIHPTCAEIFTTMEVTKSSGGDITQSGCUG
KEKLDETIGIHPTCAEIFTTMDTSKSSGGDISQKGCUG
KQLLDDTIGIHPTCGEVFTTLEITKSSGLDITQKGCUG
KKQLDSTIGIHPVCAEVFTTLSVTKRSGASILQAGCUG
--------------------------------------
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Alignment of thioredoxin glutathione reductases (TGR), thioredoxin reductase (TR) and
glutaredoxin (Grx). Cysteine and selenocysteine (U) residues involved in catalysis are
highlighted in yellow. Cysteine residues glutathionylated by oxidized glutathione are shown
in light blue. Accession numbers (ExPASy Proteomics Server): Echinococcus granulosus TGR
(Q869D6), Fasciola hepatica TGR (A8E0R8), Schistosoma mansoni TGR (Q962Y6), Schistosoma
japonicum TGR (Q5DE05), Danio rerio TGR (A8WGN7), Xenopus laevis TGR (Q66J56), human TGR
(Q86VQ6), human cytosolic TR (Q16881) and human Grx (P35754).

Bonilla et al. Supplemental Table 1. Primers used for cloning
mtTrx-EGFP
mtTGR-EGFP

6XHis-TGRGCUG

6XHis-TGRGCCG
6XHis-TGRGC*

6XHis-TGRGUCG

6XHis-TRGCUG
6XHis-mtTrx

forward

5'-CAAGCTTGTCGCCACCATGATGCTGGGTCAGAAACTC-3'

reverse

5'-AGGATCCACTTGCACAGCTCCTGAA-3'

forward

5'-CAAGCTTCGCCACCATGTTTGGCTGTCATTGTCT-3'

reverse

5'-TGGATCCCATCATCGTCAATCGCCATCA-3'

forward

5'-ATGGCTCCAATAGGTGGTTCTGC-3'

reverse

5'_GGAAGCTTGTGGATCCGAGCTAGGGATTGGTGCAGAC
CTGCAACCGATGCTTAACCTCAGCAGCCGGTTACGGT-3'

forward

5'-CGGATCCATGGCTCCAATAGGTGGTTC-3'

reverse

5'-CGTCGACTTAACCGCAGCAGCCGGTTA-3'

forward

5'-CGGATCCATGGCTCCAATAGGTGGTTC-3'

reverse

5'-GTCGACTTAACCTTAGCAGCCGGTTA-3'

forward

5'-CGGATCCATGGCTCCAATAGGTGGTTC-3'

reverse

5'_GTCGACCGATCGGGTTATTGGTGCAGACCTGCAACCGA
TTAACCACATCAGCCGGTTACGGT-3'

forward

5'-CCGGATCCCATATGAAATACGATTATGACATG-3'

reverse

5'-CGTCGACGAGCTAGGGATTGGTGCAGA-3' *

forward

5'-CGGATCCAATATTCAAGATCCTGCC-3'

reverse

5'-CAAGCTTACTACTTGCACAGCTCCTG-3'

The sequences underlined correspond to the Sec insertion sequence (SECIS) of the
E.coli formate dehydrogenase H (FDH H).
* The 6XHis-TRGCUG construct was generated using the 6XHis-TGRGCUG construct as a
template, and so the reverse primer for this construct anneals to the end of the E.coli
FDH H SECIS present in this template.
Note: To generate the 6XHis-cTrx construct the cTrx coding sequence was subcloned
from a pGEM clone provided by Cora Chalar (Universidad de la República, Uruguay).

